| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |